Revenue: The sum of all revenue fields included for a company's operating activities.
XTL Biopharmaceuticals Ltd. (XTLB) had Revenue of $0.45M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$0.45M |
$-1.03M |
|
$0.45M |
|
$0.00M |
|
$2.62M |
|
$-2.17M |
|
$1.01M |
|
$-1.16M |
|
$-1.16M |
|
$-1.03M |
|
$-1.03M |
|
$-1.03M |
|
$-1.03M |
|
$-2.17M |
|
$-1.97M |
|
6.73M |
|
7.04M |
|
$-0.20 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$1.34M |
|
$0.19M |
|
$7.21M |
|
$8.55M |
|
$2.21M |
|
-- |
|
$0.91M |
|
$3.12M |
|
$5.43M |
|
$-1.57M |
|
$5.43M |
|
8.81M |
|
| Cash Flow Statement Financials | |
$-1.62M |
|
$-0.84M |
|
$1.45M |
|
$1.40M |
|
$0.37M |
|
$-1.03M |
|
$0.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.61 |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.67% |
|
-481.60% |
|
-481.60% |
|
-437.47% |
|
-256.54% |
|
-227.72% |
|
$-1.67M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
2.29 |
|
159.43 |
|
-18.90% |
|
65.25% |
|
-12.01% |
|
-18.90% |
|
$0.62 |
|
$-0.24 |
|
$-0.23 |
|